IL-4, IL-17 and CD163 Immunoexpression and IL-6 Gene Polymorphism in Chronic Hepatitis C Patients and Associated Hepatocellular Carcinoma

Bibliographic Information
Authors: Aboushousha T.; Emad M.; Rizk G.; Ragab K.; Hammam O.; Fouad R.; Helal N.S.
Journal: Asian Pacific Journal of Cancer Prevention
Publisher: Asian Pacific Organization for Cancer Prevention
Publication Date: 1 April 2021
Volume / Issue: Volume 22 / Issue 4
Pages: 1105–1113
ISSN: 15137368
DOI: 10.31557/APJCP.2021.22.4.1105
Scopus: View on Scopus
PubMed: 33906302
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Aboushousha T., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Emad M., Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza, Egypt; Rizk G., Faculty of Biotechnology, October University for Modern Sciences and Arts, Giza, Egypt; Ragab K., Department of Hepatology and Gastroenterology, Theodor Bilharz Research Institute, Giza, Egypt; Hammam O., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Fouad R., Department of Hematology, Theodor Bilharz Research Institute, Giza, Egypt; Helal N.S., Department oF Pathology, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Objective: To assess the expression of IL-4, IL-17 and CD-163 as well as study of IL6-572 C/G gene polymorphism in chronic HCV and HCC on top of HCV. Methods: Sixty HCC specimens and 60 adjacent hepatic tissue with HCV of different grades of necro-inflammation and different stages of fibrosis. In addition to 55 HCV, 60 HCC and 50 healthy venous blood samples for evaluation of IL6-572 C/G gene polymorphism. Results: high expression of IL-4, IL-17 and CD163 in higher grades of activity, late stages of fibrosis and higher degrees of steatosis of HCV. IL-4 and CD163 showed higher expression in advanced grades of HCC, while IL-17 more expressed in lower grades. No significant difference in IL6-572 C/G gene polymorphism among studied groups regarding G/C, G/G, C/C frequencies or G and C allele’s frequencies. Conclusion: IL-4, IL-17 and CD163 were associated with HCV severity. Their expression in HCC suggests their important role in HCC development. Blocking of these proteins may be a good target to control inflammation in HCV and can hinder progression to cirrhosis then to HCC. On the other hand, IL6-572 promoter gene polymorphism is neither associated with HCV infection nor with HCC development and its progression. © 2021. All Rights Reserved.
Keywords
CD136; HCC; HCV; IL-17; IL-4; IL-6; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; Humans; Interleukin-17; Interleukin-4; Interleukin-6; Liver Neoplasms; Receptors, Cell Surface; CD163 antigen; cell surface receptor; differentiation antigen; interleukin 17; interleukin 4; interleukin 6; leukocyte antigen; tumor marker; chronic hepatitis C; genetic predisposition; genetics; human; liver cell carcinoma; liver tumor; metabolism
Citation Information
Scopus Citations: 10
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
